Cartesian Therapeutics (RNAC) Preferred Dividend Payments (2015 - 2025)
Cartesian Therapeutics (RNAC) reported Preferred Dividend Payments of $2.6 million for Q2 2025, down 37.55% year-over-year from $4.2 million in Q2 2024, and down 37.55% quarter-over-quarter from $4.2 million in Q2 2024.
Cartesian Therapeutics (RNAC) Preferred Dividend Payments (2015 - 2025) Analysis & Trends
Cartesian Therapeutics (RNAC) has 4 years of Preferred Dividend Payments data on file, last reported at $2.6 million in Q2 2025.
- Preferred Dividend Payments for Q2 2025 came in at $2.6 million, down 37.55% year-over-year; the trailing twelve-month figure through Jun 2025 was $6.8 million (up 62.45% YoY), and the FY2016 annual result was $4.6 million, down 37.75% from the prior year.
- Preferred Dividend Payments slipped to $2.6 million in Q2 2025 per RNAC's latest filing, from $4.2 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $4.2 million in Q2 2024 and troughed at $2.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.63 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Jun 30, 2016 | 2.21 Mn |
| Mar 31, 2016 | 2.36 Mn |
| Dec 31, 2015 | 2.38 Mn |
| Sep 30, 2015 | 1.84 Mn |
| Jun 30, 2015 | 1.56 Mn |